MAP 2018 - Molecular Analysis for Personalised Therapy

Oncology Meeting Resources

14 Sep - 15 Sep 2018, Paris, France

MAP 2018 - Square

The development of new biotechnologies and their application to Precision Medicine in cancer treatment is a fast-moving field. Understanding molecular alterations, their mechanisms of action and how they can apply to therapy is a challenge in medical oncology and clinical practice.

MAP 2018 is a joint initiative of Cancer Research UK, UNICANCER and ESMO and aims to provide oncologists with expert guidance on interpreting genomic alterations to design tailored treatment programmes for their patients.

Resources from MAP 2018 - Molecular Analysis for Personalised Therapy are available to ESMO member according to the presenters' agreement to release them. The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity. Meeting programme | Future ESMO meetings





Format available

https://oncologypro.esmo.org/Meeting-Resour...ecular-Analysis-for-Personalised-Therapy/PDX

Date: 14 Sep 2018
Presenter: Samuel Aparicio
Resources: Presentation, Webcast
Topic: Translational Research

https://oncologypro.esmo.org/Meeting-Resour...sis-for-Personalised-Therapy/Single-cell-PDX

Date: 14 Sep 2018
Presenter: Sohrab Shah
Resources: Presentation, Webcast
Topic: Translational Research

https://oncologypro.esmo.org/Meeting-Resour...-A-prospective-cohort-from-the-MATCH-R-study

ALK tyrosine kinase inhibitors (TKIs) have shown to be effective in the treatment of patients with ALK rearranged NSCLC. The clinical benefit is eventually limited by the acquisition of resistance to ALK TKIs by tumor cells.

Date: 14 Sep 2018
Presenter: Gonzalo Recondo
Resources: Abstract

https://oncologypro.esmo.org/Meeting-Resour...ngs-in-sequencing-programs-What-is-the-issue

Date: 14 Sep 2018
Presenter: Thierry Frébourg
Resources: Presentation, Webcast
Topic: Translational Research

https://oncologypro.esmo.org/Meeting-Resour...d-Therapy/Presentation-of-consensus-findings

Date: 14 Sep 2018
Presenter: Clare Turnbull

https://oncologypro.esmo.org/Meeting-Resour...argeting-DNA-repair-in-gynecological-cancers

Date: 14 Sep 2018
Presenter: Thomas Helleday
Topic: Gynaecological Malignancies

https://oncologypro.esmo.org/Meeting-Resour...ll-therapy-to-common-epithelial-malignancies

Date: 14 Sep 2018
Presenter: Christopher Klebanoff
Topic: Gynaecological Malignancies

https://oncologypro.esmo.org/Meeting-Resour...ncer-OC-in-BRCA1-germ-line-mutation-carriers

Cancers arising in BRCA1 mutation carriers are highly sensitive to cisplatin due to somatic inactivation of the wild-type BRCA1 allele. Accordingly, BRCA1-driven OCs usually respond well to NACT and...

Date: 14 Sep 2018
Presenter: Evgeny Imyanitov
Resources: Abstract, Presentation, Webcast
Topic: Ovarian Cancer

https://oncologypro.esmo.org/Meeting-Resour...asion-and-cancer-evolution-The-Achilles-heel

Date: 14 Sep 2018
Presenter: Charles Swanton
Resources: Presentation, Webcast

https://oncologypro.esmo.org/Meeting-Resour...Therapy/Emergent-and-emerging-kinase-targets

Date: 14 Sep 2018
Presenter: Peter Parker
Topic: Translational Research